Key words
exercise, - eccentric, - muscle fatigue, - trunk muscles, - isokinetics, - repeated
bout effect, - inflammation, - exercise induced muscle damage, - interleukin-6, -
internleukin-10, - tumor necrosis factor-α
Introduction
Eccentric exercise is known for a variety of unique features, supporting its
potential to serve as a highly efficient treatment strategy for various clinical
conditions [1]. Since high mechanical loads
can be applied, it is assumed that eccentric exercises can induce greater muscle
hypertrophy than concentric loading [2]
[3]. Also, it has been shown that eccentric
exercises induce reduced cardiovascular load [4]
[5] compared to concentric
exercises. Eccentric exercises further resulted in improved glucose tolerance,
insulin sensitivity, and serum lipid levels after exercises [6]
[7].
More recently, some studies indicated that eccentric exercises might also be able
to
positively influence inflammatory processes [8]
[9].
Eccentric exercises are often followed by a delayed-onset muscle soreness (DOMS),
temporary loss of muscle strength, swelling, reduced range of motion, and the
release of myocellular proteins [10]
[11]. Repeated application of eccentric loading
can diminish those symptoms, known as the repeated bout effect (RBE). Eccentric
muscle-damaging exercise is also often followed by local and systemic pro- and
anti-inflammatory processes [12]. To assess
the potential applicability of eccentric exercises for individuals in different
clinical populations, it is important to characterize the consequences of repeated
exercise bouts regarding muscle damage as well as inflammatory parameters. Cytokines
that are released in response to exercise seem to be rapidly excreted from the
circulation and therefore often only minor changes could be detected in serum,
especially after eccentric resistant exercises [13]. Some studies postulated that cytokine plasma levels after repeated
bouts of muscle-damaging strength exercises do not follow typical RBE
characteristics, at least for the cytokine interleukin (IL)-6 [14]
[15].
It is suggested that the release of circulating pro- and anti-inflammatory
parameters may depend on time and intensity of loading, but also on the amount of
recruited muscle mass [16]. Previous studies
often focused on unilateral loading of small muscle groups, e. g., elbow
flexors [17]
[18], or were limited to large muscles of the lower extremities,
e. g., knee flexors and extensors [15]
[19]
[20]. Only recently, Chen et al. conducted a
study investigating the effects of nine eccentric exercises that were performed in
the same session and involved a variety of muscle groups simultaneously [21]. This approach allows comparing DOMS and
strength parameters of different muscle groups, for example, but only the total
cumulative effect on plasma parameters after loading of all targeted muscle groups
can be measured and specific systemic reactions to loading of particular muscle
groups remain unanswered. To the authors’ knowledge, isolated eccentric
trunk loading protocols investigating muscle damage characteristics and inflammation
responses of the trunk encompassing musculature are lacking.
Therefore, the aim of the present pilot study was to test the feasibility of an
isokinetic protocol for repeated maximum eccentric loading of the trunk muscles to
induce muscle damage and a RBE under standardized conditions in a population of
asymptomatic participants. To investigate whether the protocol is suitable and can
be used in a subsequent main study to further characterize inflammatory responses
in
the circulation, the purpose was to determine, if clinically relevant changes of
inflammatory parameters are measurable in serum samples and if there are preliminary
indications of a RBE of these parameters under these conditions.
Materials & Methods
Participants
Nine asymptomatic volunteers were included from a university setting ([Table 1]). All participants met the
following inclusion criterion: being pain-free/asymptomatic prior to the
first measurement. Exclusion criteria were acute infection/cold,
acute/chronic injuries of the musculoskeletal system, or pathologies or
diseases that contraindicate physical activity. Participants were recreationally
active and were asked to abstain from any unaccustomed vigorous physical
activity from the week before the first measurement day until the study end. All
participants gave written informed consent for their participation. The pilot
study was conducted in accordance with the ethical standards for scientific
research [22] and was supervised by the
medical board of the University Outpatient Clinic at the University of
Potsdam.
Table 1 Anthropometric data of participants.
|
n
|
Age [years]
|
Weight [kg]
|
Height [m]
|
Phys. Activity [h/week]*
|
Overall
|
9
|
34±6
|
76±17
|
1.75±0.13
|
2.1±1.9
|
Females
|
5
|
35±7
|
64±13
|
1.65±0.07
|
2.8±2.1
|
Males
|
4
|
32±5
|
90±6
|
1.87±0.08
|
1.2±1.4
|
Data is presented as mean±SD ; *Physical activity: hours
of sport within 7 days before first measurement day.
Study design and procedure
All participants performed three isokinetic strength tests of the trunk, one
concentric (CON) and two eccentric (ECC1, ECC2), each 2 weeks apart ([Fig. 1a]). An isokinetic dynamometer
(Con-Trex MJ, TP1000 trunk module; physiomed AG, Schnaittach, Germany) was used
to assess resulting torque output during trunk flexion and extension movements.
Participants were placed inside the dynamometer in a semi-seated posture,
adjusted to align the axis of rotation to the intersection point of the
mid-axillary line and the lumbosacral junction (L5–S1 level) [23]. All tests were performed in a movement
range from 10° of trunk extension to 45° of trunk flexion
(55° of total ROM), at a rotational velocity of 60°/s
([Fig. 1b]). The following
experimental procedure was executed at each of the three measurement days
(always performed at the same time of the day): a) a warm-up trial consisting of
30 concentric repetitions; b) a resting period of 3 minutes; and c) a
testing trial consisting of a 2-minute all-out MVC task, performed in concentric
mode (CON) on the first measurement day and in eccentric mode (ECC1 and ECC2) on
the second and third measurement days ([Fig.
1a]).
Fig. 1 Measurement procedures with isokinetic trunk strength
protocols and time points of assessed outcomes. a) General
testing protocol including all three time points of measurement.
b) Isokinetic testing conditions and exemplary participant
within the isokinetic dynamometer. c) Time points of outcome
assessments before and after isokinetic testing. CON, 2-minute
concentric protocol; ECC1 and ECC2, 2-minute eccentric protocols; MVC,
maximum voluntary contraction; MS, muscle soreness; RPE, rating of
perceived exertion; VBS, venous blood sampling; CBS, capillary blood
sampling; post, immediately after exercise protocol; 4
h–168 h hours after exercise protocol.
Participants provided subjective ratings of perceived exertion (RPE; Borg scale
6–20) immediately after strength testing. Capillary blood samples from
the earlobe were taken to analyze blood lactate levels before and immediately
after each protocol (Biosen Analyzer; EKF Diagnostics, Barleben, Germany).
Muscle soreness of the trunk muscles was rated by the participants using a
numeric rating scale (NRS) from 0 (no soreness) to 10 (worst imaginable
soreness) before (0 h) and 4 h, 24 h, 48 h,
72 h and 168 h after each strength test. Venous blood samples
were taken from an antecubital forearm vein using a disposable needle and
vacutainer (S-Monovette Serum, Sarstedt AG & Co., Nümberecht,
Germany). Blood was drawn at baseline (0 h) and 4 h,
24 h, 48 h, 72 h and 168 h after each strength
test. Blood was immediately centrifuged (2000 xg, 10 min) and serum
samples were stored in aliquots at –80°C until analysis. An
overview of the outcome assessment time points before and after the isokinetic
loading protocol is presented in [Fig.
1c].
Blood analyses of markers of muscle damage and inflammation
Creatine kinase (CK), aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and C-reactive protein (CRP) concentrations were measured of samples
taken pre (0 h) and 4 h, 24 h, 48 h,
72 h, 168 h after each strength test. Analysis was done with the
Pentra C400 clinical chemistry analyzer equipped with Pentra cuvette segments
(Axon Lab AG, Baden, Switzerland) by using the calibrator reagents (Pentra CRP
CAL, AXON MC) according to the manufacturer’s instructions.
Cytokine concentrations were determined in serum samples taken before
(0 h), 24 h, 48 h, 72 h and 168 h after
each strength test. Commercially available high-sensitivity enzyme-linked
immunosorbent assay (ELISA) kits (IBL International, Hamburg, Germany) were
used. IL-6, IL-10 and tumor necrosis factor α (TNF-α) were
analyzed using 50 µl of serum samples according to
manufacturer’s instructions.
Data analysis and statistics
Maximum peak torque [Nm] of trunk extensors (CON: trunk extension movement; ECC1,
ECC2: trunk flexion movement) and trunk flexors (CON: trunk flexion movement;
ECC1, ECC2: trunk extension movement) were derived from the mean value of the
three highest out of five repetitions at the beginning (first five repetitions),
midpoint (repetitions 23 to 27) and end (last five repetitions) of each trial
[24]. Additionally, the resulting work
[J] over the whole trial of CON, ECC1, and ECC2 was calculated during trunk
flexion and extension separately. Peak torque reduction was calculated as peak
torque difference [Nm] at mid- and endpoint of the trial in relation to the
beginning. Overall responses of muscle damage and inflammation markers were
stated as “area under the curve” (AUC), which was calculated for
each parameter over time from pre-exercise (0 h) to 72 h after
each loading trial.
Peak torque, work, RPE, blood lactate, and markers of muscle damage and
inflammation were presented descriptively as mean±standard deviation
(SD). Statistical analyses were done for peak torque differences [Nm] between
conditions (CON vs. ECC1 vs. ECC2) at the beginning as well as for torque
reduction [Nm] within each condition (mid- vs. endpoints) for trunk flexor
torque and trunk extensor torque separately. Further, comparisons between
conditions (CON vs. ECC1 vs. ECC2) were done for total work, RPE
(post-exercise), blood lactate (pre- and post-exercise) as well as muscle damage
and inflammation markers for AUC and at the time point of post-ECC1 peak. All
statistical analyses were done by Friedman’s ANOVA with Dunn’s
multiple comparisons test as data deviated from normal distribution (Shapiro
Wilk test). The level of significance was set at α<0.05.
Results
Strength measurements
CON resulted in 48±1 repetitions of trunk flexion and extension during
the 2-minute all-out protocol, ECC1 in 50±0 and ECC2 in 50±1
repetitions, respectively. Higher mean peak torques were found descriptively at
the beginning for both flexor and extensor torque in ECC1 and ECC2 compared to
CON ([Table 2]) with statistically
significant differences for extensor torque between CON and ECC1
(p=0.003) and for flexor torque between CON and ECC1 (p=0.003)
as well as CON and ECC2 (p=0.007). Peak torque reduction showed lower
values during the mid- and endpoint for both ECC1 and ECC2 compared to CON
([Fig. 2d/h]). Individual
courses of flexor and extensor torque during CON, ECC1 and ECC2 for each
participant are shown in [Fig. 2]. Total
work differed statistically significantly between CON and ECC1 (extensor torque
p=0.007; flexor torque p=0.014), and between CON and ECC2
(extensor torque p=0.029) ([Table
2]). Also, blood lactate accumulation post-exercise differed
statistically significantly between CON and both eccentric bouts (ECC1:
p=0.029, ECC2: p=0.049). In contrast, blood lactate pre-exercise
and RPE post-exercise did not differ between the three protocols ([Table 2]).
Fig. 2 Trunk extensor and flexor peak torque during the 2-minute
all-out protocols. CON, 2-minute concentric protocol (solid line); ECC1
and ECC2, 2-minute eccentric protocol (dotted line and dash-dotted
line); Begin, beginning; Mid, midpoint; End, endpoint.
a–c) Individual courses of trunk extensor peak torque
for each participant. e–g) Individual courses of trunk
flexor peak torque. d, h) Mean peak torque courses with
differences relative to Begin.
Table 2 Peak torque, total work, blood lactate, and RPE
for the maximal concentric and repeated maximal eccentric loading of
the trunk.
|
Movement direction
|
Peak torque [Nm]
|
Work [J]
|
Blood Lactate [mmol/l]
|
RPE [Score]
|
|
|
Begin
|
Mid
|
End
|
Begin to End
|
pre
|
post
|
post
|
CON
|
Extension
|
272±114
|
218±85
|
187±71
|
7279±2853
|
0.9±0.4
|
6.9±2.3
|
18.9±1.2
|
|
Flexion
|
156±68
|
116±50
|
93±34
|
4273±1920
|
|
|
|
ECC1
|
Extension
|
189±93#
|
161±83
|
142±72
|
5707±3254#
|
1.0±0.3
|
4.9±2.3#
|
18.8±1.3
|
|
Flexion
|
331±147
|
293±141
|
265±120
|
10369±4638#
|
|
|
|
ECC2
|
Extension
|
186±94#
|
154±86
|
140±74
|
5368±3154
|
0.9±0.3
|
4.8±2.3#
|
18.7±1.1
|
|
Flexion
|
309±130
|
270±107
|
239±87
|
9311±3487#
|
|
|
|
Data are presented as mean±SD for N=9. CON, 2-minute
concentric protocol; ECC1, ECC2, 2-minute eccentric protocol; RPE,
ratings of perceived exertion. Statistically significant differences
(p<0.05) for CON vs. ECC1 or CON vs. ECC2 are indicated by (#);
Friedman test with Dunn’s multiple comparisons test.
Markers of muscle damage
Perceived muscle soreness increased following CON with a peak value at
24 h post-exercise (NRS 2.0±1.7) and returned to baseline after
72 h ([Fig. 3a]). ECC1 induced a
delayed but higher increase of muscle soreness peaking at 48 h (NRS
4.9±2.9) and reaching statistical significance in comparison to CON
(p=0.049; [Table 3]). Muscle
soreness remained increased (NRS 2.4±2.7) at 72 h post-ECC1.
Following ECC2, muscle soreness increase was statistically significantly lower
at 48 h compared to ECC1 (p=0.049).
Fig. 3 Changes in markers of muscle damage and inflammation after
the 2-minute all-out protocols. a) Perceived muscle soreness was
assessed using a Numeric Rating Scale (NRS 0–10). Concentrations
of muscle enzymes (b–d) and inflammatory parameters
(e, f) were assessed in serum samples. Data is
presented as mean±SD for N=7 (A) and
N=7–9 (B-F). CON, 2-minute concentric protocol; ECC1,
ECC2, 2-minute eccentric protocol. Note the logarithmic scale on the y
axis of graph B.
Table 3 Changes in markers of muscle damage and
inflammation over 72 h after the 2-minute all-out
protocols. Markers of muscle damage and inflammation were
assessed before and at different time points after each exercise
bout. Peak time after ECC1 was selected (according to [Fig. 3]) and values of each
parameter at this time point after CON, ECC1, and ECC2 were
statistically analyzed. Area under the curve (AUC) was calculated
for the period of pre- (0 h) to 72 h
post-exercise.
|
CON
|
ECC1
|
ECC2
|
Muscle Soreness
|
|
|
|
[NRS] at peak (48 h post)
|
1.1±1.3
|
4.9±2.9#,$
|
1.3±1.1
|
AUC [NRS*72 h]
|
82±61
|
226±143#,$
|
87±73
|
Creatine kinase (CK)
|
|
|
|
[U/l] at peak (72 h post)
|
356.9±657.5
|
15998.9±20520.2#,$
|
408.7±692.5
|
AUC [U/l*72 h]
|
16651±14282
|
595084±808004$
|
15764±16472
|
Aspartate aminotransferase (AST)
|
|
|
|
[U/l] at peak (72 h post)
|
22.4±5.1
|
190.9±240.3#
|
22.8±6.6
|
AUC [U/l*72 h]
|
1580±416
|
7513±8371
|
1566±265
|
Alanine aminotransferase (ALT)
|
|
|
|
[U/l] at peak (72 h post)
|
23.0±10.2
|
66.4±68.1
|
24.0±7.6
|
AUC [U/l*72 h]
|
1552±705
|
2803±1901
|
1788±579
|
C-reactive protein (CRP)
|
|
|
|
[U/l] at peak (72 h post)
|
0.6±0.8
|
1.2±1.9
|
0.4±0.4
|
AUC [U/l*72 h]
|
78±105
|
42±40
|
35±29
|
Interleukin-6 (IL-6)
|
|
|
|
[pg/ml] at peak (72 h post)
|
0.4±0.4
|
1.0±0.9
|
0.7±0.3
|
AUC [pg/ml*72 h]
|
33±32
|
58±39
|
43±25
|
Tumor necrosis factor-α (TNF-α)
|
|
|
|
[pg/ml]
|
n.d.
|
n.d.
|
n.d.
|
Interleukin-10 (IL-10)
|
|
|
|
[pg/ml]
|
n.d.
|
n.d.
|
n.d.
|
Data are presented as mean±SD for N=7 (muscle soreness)
or N=9. CON, 2-minute concentric protocol; ECC1, ECC2, 2-minute
eccentric protocol; n.d., not detectable (high sensitivity ELISA, limit
of detection (LoD) (TNF-α)=0.13 pg/ml;
LoD (IL-10)=0.05 pg/ml). Statistically
significant differences (p<0.05) are indicated by (#) for CON
vs. ECC1 and ($) for ECC1 vs. ECC2; Friedman test with
Dunn’s multiple comparisons test.
Serum concentration of the muscle enzyme CK increased after CON at 72 h
post-exercise ([Fig. 3b], [Table 3]). ECC1 induced a high increase of
CK serum level, which peaked at 72 h post-exercise and was statistically
significantly higher compared to CON (p=0.007). This increase had
completely abated after ECC2 (p=0.029) and reached a level comparable to
post-CON. Overall, CK response showed a high variability between participants,
indicated by high standard deviations. Two participants showed no increase of CK
at all measured time points, whereas another showed a 375-fold increase in CK at
72 h post-ECC1. AST and ALT ([Fig. 3c,
d]) serum concentrations increased only after ECC1, peaked at
72 h post-exercise ([Table 3])
and remained elevated for 7 days after muscle-damaging exercise. The overall
response of the main markers of muscle damage 72 h after loading had
significantly abated after ECC2 compared to ECC1 (AUC: muscle soreness:
p=0.049, CK: p=0.029; [Table
3]).
Markers of inflammation
Before CON, baseline mean CRP was higher compared to all other measured time
points ([Fig. 3e]), caused by slightly
increased CRP levels of two single participants. Mean serum CRP levels did not
change over the observed period and were not statistically significant different
72 h after CON, ECC1, and ECC2 ([Table
3]).
Although serum levels of IL-6 remained unchanged after CON, mean values increased
after ECC1 by 2-fold compared to pre-exercise (pre:
0.5±0.3 pg/ml, 72 h post:
1.0±0.9 pg/ml; [Fig.
3f]). Overall IL-6 response was enhanced after ECC1 compared to CON,
but differences did not reach statistical significance (AUC, p=0.102;
[Table 3]). After ECC2, IL-6 levels
and overall IL-6 answers were, although not statistically significant, lower
than post-ECC1 but higher than after CON. In total, IL-6 responses showed a high
inter-individual variability. While three participants showed no change in
systemic IL-6 levels after ECC1, the IL-6 levels in serum samples from the other
participants increased post-ECC1 by 1.7-fold up to 8.8-fold compared to
pre-ECC1.
Serum levels of cytokines TNF-α and IL-10 were mainly below the detection
limits at all analyzed time points.
Discussion
The present pilot study investigated the feasibility of an isokinetic eccentric
maximum trunk loading protocol to assess muscle damage and (anti-) inflammatory
responses following single and repeated bouts of trunk muscle exercise. Comparison
of assessed force parameters of the three applied protocols yielded an increased
peak torque output, accompanied by a reduced decline of torque over the 2-minute
all-out duration, and an increased total work for both eccentric protocols in
comparison to the concentric protocol. Repeated bouts of eccentric loading resulted
in unaltered torque and work-related outcomes. Despite the presence of highly
increased markers of muscle damage, especially in CK, only a slight increase in
serum IL-6 level after the first eccentric loading was observed, which was
descriptively lowered after the second eccentric exercise session. Neither
pro-inflammatory cytokine TNF-α nor anti-inflammatory cytokine IL-10 were
detectable in serum samples taken before or after the protocols, raising the
question as to whether there are systemically relevant inflammatory reactions after
exercise-induced trunk muscle damage, at least in young asymptomatic
participants.
Strength measurements
All trunk strength protocols under maximal effort condition were successfully
performed, without any adverse events being detected throughout the study and
thus were proven to be feasible for all participating volunteers. Comparable
amounts of total load repetition were realized across all three testing
protocols with minor differences being expected to be caused by alterations at
the turning points of movement directions. In line with physiological
anticipation, torque output was increased and torque decline over time (at mid-
and endpoint of trial) was reduced in both eccentric protocols compared to the
concentric protocol [2]
[3]
[25]. Intra-individual torque comparisons ([Fig 2a–c, e–g]) revealed
further a homogeneous torque decline over time for all participants. Decreased
blood lactate in eccentric, at comparable levels of RPE across all protocols,
further confirmed previously reported characteristics of eccentric loading
protocols [2]
[26]
[27]
[28]. Thus, the protocol
proved to be able to elicit distinct loading situations, both in concentric and
eccentric contraction modes to investigate related muscle damage.
Muscle damage markers
Delayed-onset muscle soreness and increased serum concentrations of
muscle-derived enzymes ([Fig. 2], [Table 1]) were induced by the first
eccentric protocol. Even so, there was a huge inter-individual variation that
might be linked to the phenomenon of so-called high, moderate, or non-CK
responders [29]. Unfortunately
standardized definitions of responder categories are lacking [30]
[31]. Therefore and because of the small sample size in this pilot
study, no subgroup analyses were performed. However, the overall abolished
response in muscle damage markers after the repeated eccentric loading of the
trunk were in line with similar findings after repeated eccentric exercises of
other muscle groups [32]
[33]. Accordingly, these findings provide
evidence for the presence of a RBE after recurrent isolated maximal eccentric
loading of the trunk muscles.
Inflammatory markers
Pro-inflammatory cytokine TNF-α was undetectable at all analyzed time
points ([Table 2]). Since TNF-α
is relevant to local rather than systemic inflammatory responses after eccentric
loading, no detectable serum levels or at least no changes were expected in
asymptomatic participants [12]. IL-6 is
the most commonly studied cytokine in terms of eccentric contractions, but acute
eccentric loading of knee extensors and elbow flexors led to contradictory
results regarding the response characteristics [17]
[18]
[19]. In this pilot study, no increase of
serum IL-6 after CON, but a 2-fold increase 72 h after ECC1 ([Fig. 3b], [Table 2]) was detected. IL-6 is able to
induce the acute-phase protein CRP, and the overall 3-fold CRP increase after
ECC1 (versus pre-exercise, [Fig. 3a])
slightly reflected the observed IL-6 increase, albeit without reaching
statistical significance and showing a high variability across participants. A
study with obese elderly women identified high IL-6 responders after acute
eccentric stress, which was not directly related to high CK responses, so that a
causal relationship between IL-6 and CK increase remains questionable [30]. Additionally, it should be considered
that the huge inter-individual variability seen in the change of these
parameters might be caused by factors that were not controlled and tested for
within this pilot study. CRP is involved in the innate immune signaling and
therefore influenced by numerous immune-stimulating conditions like infections
[34]. Although we excluded
participants with upper respiratory tract infections, two participants started
with a slightly increased CRP level probably caused by an unrecognized
infection. Moreover, eccentric exercise-induced increases of CRP and IL-6 could
be influenced by nutritional status [35]
[36], which was not
controlled or documented. Because of the overall minor and highly variable IL-6
response, an evaluation of the effects of repeated eccentric loadings is
limited. Nevertheless, the IL-6 response after ECC2 tended to be lower than
after ECC1 two weeks earlier, indicating the presence of an RBE for IL-6.
Results from previous studies regarding effects of repeated eccentric bouts on
systemic IL-6 level are limited and inconclusive. Willoughby et al. showed no
differences in plasma IL-6 and mRNA levels between two eccentric bouts performed
three weeks apart [15]. Deyhle et al.
showed a decrease of intra-muscular IL-6 after a first eccentric bout, which was
abolished after repetition [37]. As
intra-muscular pro-inflammatory parameters increased and the anti-inflammatory
mediator IL-4 decreased, the authors hypothesized that following a second bout
of lengthening contractions an enhanced inflammatory response might occur [37]. In contrast, other studies showed a
systemic increase of the anti-inflammatory cytokine IL-10, both in response to
prolonged high-intensity downhill exercise and eccentric cycling [38]
[39] as well as after isolated contraction of the elbow flexors [17]
[18]. In our study investigating a large group of trunk muscles, IL-10
was not detectable before or after eccentric loading. Similarly, other studies
loading large muscle groups (knee extensors, calf muscles) also reported
unchanged [20] or even undetectable IL-10
levels [19]. These observations, in line
with our findings, may indicate that not only intensity and duration of
eccentric loading and extent of muscle damage are influencing factors for a
systemic anti-inflammatory response [40]
[41] but also the loaded
muscle group. Particularly the lower extremities and the trunk are repeatedly
exposed to high loads during decelerating movements and work against gravity
during daily life activities. Therefore, these muscle groups may be
pre-conditioned for eccentric loads leading to an attenuated inflammatory
response following maximal eccentric bouts.
Clinical relevance
Although the present pilot study was conducted with young asymptomatic
participants, potential influences of acute eccentric exercise bouts on systemic
levels of inflammatory mediators in patients could be of clinical interest. For
example, people with a low physical fitness level and overweight or obesity
often show so-called low-grade systemic inflammation [42]. Exercise in general is known for its
anti-inflammatory effects [43] and
especially eccentric training was recently discussed as a promising intervention
strategy for patients with obesity or metabolic disorders [44]. However, prior to application it needs
to be clarified which eccentric exercise regimen (involved muscles, duration,
intensity, and frequency), should be applied in different clinical populations
and if acute eccentric loading of isolated muscle groups could be sufficient to
induce anti-inflammatory responses. In previous studies, running downhill [6] and descending stairs [45], but also eccentric loading of
individual muscle groups [46] showed an
improvement in relevant metabolic parameters in older and/or overweight
adults. It is particularly important to clarify whether loading of different
(small and large) muscle groups triggers different inflammatory reactions and if
loading of the trunk muscles is an appropriate approach to induce relevant
systemic reactions in patients.
Limitations
Due to the asymptomatic young participants involved, no conclusion can be drawn
for clinical populations. Moreover, the small sample size and heterogeneity of
participant’s CK responses after maximal eccentric loading limit the
generalizability of the results. Although the chosen trunk protocol proved to be
feasible and the assessed performance parameters revealed typical loading
characteristics of an eccentric maximum load exercise, the duration of the
eccentric loading may not have been sufficient to trigger an inflammatory
response. These limitations must be considered for future studies.
The present pilot study proved that a 2-minute all-out eccentric strength
protocol of the trunk is feasible to induce characteristic indicators of muscle
damage in the trunk, which abate after a second maximal eccentric bout two weeks
later. It further provided preliminary indications that despite the
muscle-damaging exercise of a large muscle group, only weak systemic
pro-inflammatory responses with little evidence for the presence of a repeated
bout effect for IL-6, and no measurable changes in serum anti-inflammatory
parameters might be elicited in asymptomatic adults. Further investigations are
required to test whether these characteristics are representative for a specific
response of the trunk muscles being pre-conditioned by the frequent eccentric
loading during daily life.